{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:41:38Z","timestamp":1784302898513,"version":"3.55.0"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,31]]},"DOI":"10.7759\/cureus.95792","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:30:58Z","timestamp":1761895858000},"source":"Crossref","is-referenced-by-count":2,"title":["Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Diabetes and Obesity: Implications for Periodontology and Family Dentistry"],"prefix":"10.7759","author":[{"given":"Asmaa A","family":"Almohammad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara K","family":"Aldossari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyad A","family":"Sukumbaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raniah  A","family":"Faden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona  A","family":"Almutairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noura H","family":"Al-Harbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majida Y","family":"Al-Saaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bandary S","family":"Almarshedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Entesar A","family":"Alharabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafaa  A","family":"Alhazri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz M","family":"Altalhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.122065","article-title":"Polymeric nanotechnologies for the treatment of periodontitis: a chronological review","volume":"625","author":"Uskokovi\u0107 V","year":"2022","unstructured":"Uskokovi\u0107 V, Pej\u010di\u0107 A, Koliqi R, An\u0111elkovi\u0107 Z. Polymeric nanotechnologies for the treatment of periodontitis: a chronological review. Int J Pharm. 2022, 625:122065. 10.1016\/j.ijpharm.2022.122065","journal-title":"Int J Pharm"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56060272","article-title":"Periodontitis, low-grade inflammation and systemic health: a scoping review","volume":"56","author":"Cecoro G","year":"2020","unstructured":"Cecoro G, Annunziata M, Iuorio MT, Nastri L, Guida L. Periodontitis, low-grade inflammation and systemic health: a scoping review. Medicina (Kaunas). 2020, 56:10.3390\/medicina56060272","journal-title":"Medicina (Kaunas)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.2011.01824.x","article-title":"Overweight and obesity predict time to periodontal disease progression in men","volume":"39","author":"Gorman A","year":"2012","unstructured":"Gorman A, Kaye EK, Apovian C, Fung TT, Nunn M, Garcia RI. Overweight and obesity predict time to periodontal disease progression in men. J Clin Periodontol. 2012, 39:107-14. 10.1111\/j.1600-051X.2011.01824.x","journal-title":"J Clin Periodontol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/0022034510375830","article-title":"Oxidative stress, systemic inflammation, and severe periodontitis","volume":"89","author":"D'Aiuto F","year":"2010","unstructured":"D'Aiuto F, Nibali L, Parkar M, Patel K, Suvan J, Donos N. Oxidative stress, systemic inflammation, and severe periodontitis. J Dent Res. 2010, 89:1241-6. 10.1177\/0022034510375830","journal-title":"J Dent Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-015-0073-z","article-title":"Influence of type 2 diabetes on local production of inflammatory molecules in adults with and without chronic periodontitis: a cross-sectional study","volume":"15","author":"Mohamed HG","year":"2015","unstructured":"Mohamed HG, Idris SB, Ahmed MF, \u00c5str\u00f8m AN, Mustafa K, Ibrahim SO, Mustafa M. Influence of type 2 diabetes on local production of inflammatory molecules in adults with and without chronic periodontitis: a cross-sectional study. BMC Oral Health. 2015, 15:86. 10.1186\/s12903-015-0073-z","journal-title":"BMC Oral Health"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/728987","article-title":"Tumor necrosis factor- \u03b1 and interleukin-6: potential interorgan inflammatory mediators contributing to destructive periodontal disease in obesity or metabolic syndrome","volume":"2013","author":"Khosravi R","year":"2013","unstructured":"Khosravi R, Ka K, Huang T, Khalili S, Nguyen BH, Nicolau B, Tran SD. Tumor necrosis factor- \u03b1 and interleukin-6: potential interorgan inflammatory mediators contributing to destructive periodontal disease in obesity or metabolic syndrome. Mediators Inflamm. 2013, 2013:728987. 10.1155\/2013\/728987","journal-title":"Mediators Inflamm"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-018-0253-4","article-title":"Periodontitis affects glucoregulatory hormones in severely obese individuals","volume":"43","author":"Solini A","year":"2019","unstructured":"Solini A, Suvan J, Santini E, et al.. Periodontitis affects glucoregulatory hormones in severely obese individuals. Int J Obes (Lond). 2019, 43:1125-9. 10.1038\/s41366-018-0253-4","journal-title":"Int J Obes (Lond)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.2009.01417.x","article-title":"Periodontitis and risk for atherosclerosis: an update on intervention trials","volume":"36","author":"Tonetti MS","year":"2009","unstructured":"Tonetti MS. Periodontitis and risk for atherosclerosis: an update on intervention trials. J Clin Periodontol. 2009, 36:15-9. 10.1111\/j.1600-051X.2009.01417.x","journal-title":"J Clin Periodontol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy SM","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, et al.. Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005, 112:2735-52. 10.1161\/CIRCULATIONAHA.105.169404","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel RH","year":"2005","unstructured":"Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005, 365:1415-28. 10.1016\/s0140-6736(05)66378-7","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/JPER.17-0384","article-title":"Insulin resistance predicts the risk of gingival\/periodontal inflammation","volume":"89","author":"Andriankaja OM","year":"2018","unstructured":"Andriankaja OM, Mu\u00f1oz-Torres FJ, Vivaldi-Oliver J, Leroux BG, Campos M, Joshipura K, P\u00e9rez CM. Insulin resistance predicts the risk of gingival\/periodontal inflammation. J Periodontol. 2018, 89:549-57. 10.1002\/JPER.17-0384","journal-title":"J Periodontol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/154405910708600503","article-title":"Obesity, inflammation, and periodontal disease","volume":"86","author":"Pischon N","year":"2007","unstructured":"Pischon N, Heng N, Bernimoulin JP, Kleber BM, Willich SN, Pischon T. Obesity, inflammation, and periodontal disease. J Dent Res. 2007, 86:400-9. 10.1177\/154405910708600503","journal-title":"J Dent Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0210072","article-title":"Adipose tissue macrophages: their role in adipose tissue remodeling","volume":"88","author":"Suganami T","year":"2010","unstructured":"Suganami T, Ogawa Y. Adipose tissue macrophages: their role in adipose tissue remodeling. J Leukoc Biol. 2010, 88:33-9. 10.1189\/jlb.0210072","journal-title":"J Leukoc Biol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2009.07.031","article-title":"Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome","volume":"314","author":"Maury E","year":"2010","unstructured":"Maury E, Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol. 2010, 314:1-16. 10.1016\/j.mce.2009.07.031","journal-title":"Mol Cell Endocrinol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2005.01.006","article-title":"Adipose tissue as an active endocrine organ: recent advances","volume":"5","author":"Gimeno RE","year":"2005","unstructured":"Gimeno RE, Klaman LD. Adipose tissue as an active endocrine organ: recent advances. Curr Opin Pharmacol. 2005, 5:122-8. 10.1016\/j.coph.2005.01.006","journal-title":"Curr Opin Pharmacol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/s0039-9140(99)00029-6","article-title":"Validation of a high performance liquid chromatography analysis for the determination of noradrenaline and adrenaline in human urine with an on-line sample purification","volume":"50","author":"Hansen \u00c5M","year":"1999","unstructured":"Hansen \u00c5M, Kristiansen J, Nielsen JL, et al.. Validation of a high performance liquid chromatography analysis for the determination of noradrenaline and adrenaline in human urine with an on-line sample purification. Talanta. 1999, 50:367-79. 10.1016\/s0039-9140(99)00029-6","journal-title":"Talanta"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(87)91194-9","article-title":"Glucagon-like peptide-1 7-36: a physiological incretin in man","volume":"330","author":"Kreymann B","year":"1987","unstructured":"Kreymann B, Ghatei MA, Williams G, et al.. Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet. 1987, 330:1300-4. 10.1016\/s0140-6736(87)91194-9","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2006.01.004","article-title":"The biology of incretin hormones","volume":"3","author":"Drucker DJ","year":"2006","unstructured":"Drucker DJ. The biology of incretin hormones. Cell Metab. 2006, 3:153-65. 10.1016\/j.cmet.2006.01.004","journal-title":"Cell Metab"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng Z","year":"2024","unstructured":"Zheng Z, Zong Y, Ma Y, Tian Y, Pang Y, Zhang C, Gao J. Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Signal Transduct Target Ther. 2024, 9:234. 10.1038\/s41392-024-01931-z","journal-title":"Signal Transduct Target Ther"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.678055","article-title":"The interplay of glucagon-like peptide-1 receptor trafficking and signalling in pancreatic beta cells","volume":"12","author":"Marzook A","year":"2021","unstructured":"Marzook A, Tomas A, Jones B. The interplay of glucagon-like peptide-1 receptor trafficking and signalling in pancreatic beta cells. Front Endocrinol (Lausanne). 2021, 12:678055. 10.3389\/fendo.2021.678055","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1210\/en.2010-0289","article-title":"Glucagon-like peptide-1 receptor knockout mice are protected from high-fat diet-induced insulin resistance","volume":"151","author":"Ayala JE","year":"2010","unstructured":"Ayala JE, Bracy DP, James FD, Burmeister MA, Wasserman DH, Drucker DJ. Glucagon-like peptide-1 receptor knockout mice are protected from high-fat diet-induced insulin resistance. Endocrinology. 2010, 151:4678-87. 10.1210\/en.2010-0289","journal-title":"Endocrinology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.665537","article-title":"The insulin response to oral glucose in GIP and GLP-1 receptor knockout mice: review of the literature and stepwise glucose dose response studies in female mice","volume":"12","author":"Ahr\u00e9n B","year":"2021","unstructured":"Ahr\u00e9n B, Yamada Y, Seino Y. The insulin response to oral glucose in GIP and GLP-1 receptor knockout mice: review of the literature and stepwise glucose dose response studies in female mice. Front Endocrinol (Lausanne). 2021, 12:665537. 10.3389\/fendo.2021.665537","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2012.140","article-title":"GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus","volume":"8","author":"Meier JJ","year":"2012","unstructured":"Meier JJ. GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus. Nat Rev Endocrinol. 2012, 8:728-42. 10.1038\/nrendo.2012.140","journal-title":"Nat Rev Endocrinol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2016.1531","article-title":"Association of bile duct and gallbladder diseases with the use of incretin-based drugs in patients with type 2 diabetes mellitus","volume":"176","author":"Faillie JL","year":"2016","unstructured":"Faillie JL, Yu OH, Yin H, Hillaire-Buys D, Barkun A, Azoulay L. Association of bile duct and gallbladder diseases with the use of incretin-based drugs in patients with type 2 diabetes mellitus. JAMA Intern Med. 2016, 176:1474-81. 10.1001\/jamainternmed.2016.1531","journal-title":"JAMA Intern Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903822","article-title":"Liraglutide in children and adolescents with type 2 diabetes","volume":"381","author":"Tamborlane WV","year":"2019","unstructured":"Tamborlane WV, Barrientos-P\u00e9rez M, Fainberg U, et al.. Liraglutide in children and adolescents with type 2 diabetes. N Engl J Med. 2019, 381:637-46. 10.1056\/NEJMoa1903822","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(18)31773-2","article-title":"Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial","volume":"392","author":"O\u2019Neil PM","year":"2018","unstructured":"O\u2019Neil PM, Birkenfeld AL, McGowan B, et al.. Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. Lancet. 2018, 392:637-49. 10.1016\/s0140-6736(18)31773-2","journal-title":"Lancet"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.05.007","article-title":"An inter-organ neural circuit for appetite suppression","volume":"185","author":"Zhang T","year":"2022","unstructured":"Zhang T, Perkins MH, Chang H, Han W, de Araujo IE. An inter-organ neural circuit for appetite suppression. Cell. 2022, 185:2478-94.e28. 10.1016\/j.cell.2022.05.007","journal-title":"Cell"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00013.2014","article-title":"Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease","volume":"95","author":"Sandoval DA","year":"2015","unstructured":"Sandoval DA, D'Alessio DA. Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease. Physiol Rev. 2015, 95:513-48. 10.1152\/physrev.00013.2014","journal-title":"Physiol Rev"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2013.04.008","article-title":"Pharmacology, physiology, and mechanisms of incretin hormone action","volume":"17","author":"Campbell JE","year":"2013","unstructured":"Campbell JE, Drucker DJ. Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab. 2013, 17:819-37. 10.1016\/j.cmet.2013.04.008","journal-title":"Cell Metab"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio LL","year":"2007","unstructured":"Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology. 2007, 132:2131-57. 10.1053\/j.gastro.2007.03.054","journal-title":"Gastroenterology"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2337\/db14-1051","article-title":"PKA enhances the acute insulin response leading to the restoration of glucose control","volume":"64","author":"Kaihara KA","year":"2015","unstructured":"Kaihara KA, Dickson LM, Ellenbroek JH, Orr CM, Layden BT, Wicksteed B. PKA enhances the acute insulin response leading to the restoration of glucose control. Diabetes. 2015, 64:1688-97. 10.2337\/db14-1051","journal-title":"Diabetes"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst JJ","year":"2007","unstructured":"Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007, 87:1409-39. 10.1152\/physrev.00034.2006","journal-title":"Physiol Rev"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1530\/JME-15-0316","article-title":"Targeting cAMP\/PKA pathway for glycemic control and type 2 diabetes therapy","volume":"57","author":"Yang H","year":"2016","unstructured":"Yang H, Yang L. Targeting cAMP\/PKA pathway for glycemic control and type 2 diabetes therapy. J Mol Endocrinol. 2016, 57:R93-108. 10.1530\/JME-15-0316","journal-title":"J Mol Endocrinol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2017.12.015","article-title":"Eriodictyol stimulates insulin secretion through cAMP\/PKA signaling pathway in mice islets","volume":"820","author":"Hameed A","year":"2018","unstructured":"Hameed A, Hafizur RM, Hussain N, et al.. Eriodictyol stimulates insulin secretion through cAMP\/PKA signaling pathway in mice islets. Eur J Pharmacol. 2018, 820:245-55. 10.1016\/j.ejphar.2017.12.015","journal-title":"Eur J Pharmacol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12993","article-title":"cAMP signalling in insulin and glucagon secretion","volume":"19","author":"Tengholm A","year":"2017","unstructured":"Tengholm A, Gylfe E. cAMP signalling in insulin and glucagon secretion. Diabetes Obes Metab. 2017, 19:42-53. 10.1111\/dom.12993","journal-title":"Diabetes Obes Metab"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1093\/abbs\/gmv115","article-title":"The pleiotropic role of exchange protein directly activated by cAMP 1 (EPAC1) in cancer: implications for therapeutic intervention","volume":"48","author":"Almahariq M","year":"2016","unstructured":"Almahariq M, Mei FC, Cheng X. The pleiotropic role of exchange protein directly activated by cAMP 1 (EPAC1) in cancer: implications for therapeutic intervention. Acta Biochim Biophys Sin (Shanghai). 2016, 48:75-81. 10.1093\/abbs\/gmv115","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.2337\/db12-1013","article-title":"\u03b2-Cell-specific protein kinase A activation enhances the efficiency of glucose control by increasing acute-phase insulin secretion","volume":"62","author":"Kaihara KA","year":"2013","unstructured":"Kaihara KA, Dickson LM, Jacobson DA, Tamarina N, Roe MW, Philipson LH, Wicksteed B. \u03b2-Cell-specific protein kinase A activation enhances the efficiency of glucose control by increasing acute-phase insulin secretion. Diabetes. 2013, 62:1527-36. 10.2337\/db12-1013","journal-title":"Diabetes"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2022.104896","article-title":"Protective role of IGF-1 and GLP-1 signaling activation in neurological dysfunctions","volume":"142","author":"Bhalla S","year":"2022","unstructured":"Bhalla S, Mehan S, Khan A, Rehman MU. Protective role of IGF-1 and GLP-1 signaling activation in neurological dysfunctions. Neurosci Biobehav Rev. 2022, 142:104896. 10.1016\/j.neubiorev.2022.104896","journal-title":"Neurosci Biobehav Rev"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1677\/JOE-06-0191","article-title":"The emerging role of FOXO transcription factors in pancreatic beta cells","volume":"193","author":"Glauser DA","year":"2007","unstructured":"Glauser DA, Schlegel W. The emerging role of FOXO transcription factors in pancreatic beta cells. J Endocrinol. 2007, 193:195-207. 10.1677\/JOE-06-0191","journal-title":"J Endocrinol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.2337\/db14-0153","article-title":"GABA promotes human \u03b2-cell proliferation and modulates glucose homeostasis","volume":"63","author":"Purwana I","year":"2014","unstructured":"Purwana I, Zheng J, Li X, et al.. GABA promotes human \u03b2-cell proliferation and modulates glucose homeostasis. Diabetes. 2014, 63:4197-205. 10.2337\/db14-0153","journal-title":"Diabetes"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12165","article-title":"Glucagon-like peptide-1: modulator of \u03b2-cell dysfunction and death","volume":"15","author":"Rondas D","year":"2013","unstructured":"Rondas D, D'Hertog W, Overbergh L, Mathieu C. Glucagon-like peptide-1: modulator of \u03b2-cell dysfunction and death. Diabetes Obes Metab. 2013, 15:185-92. 10.1111\/dom.12165","journal-title":"Diabetes Obes Metab"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.2337\/db14-1671","article-title":"Hepato-incretin function of GLP-1: novel concept and target in type 1 diabetes","volume":"64","author":"Ahr\u00e9n B","year":"2015","unstructured":"Ahr\u00e9n B. Hepato-incretin function of GLP-1: novel concept and target in type 1 diabetes. Diabetes. 2015, 64:715-7. 10.2337\/db14-1671","journal-title":"Diabetes"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.2337\/db14-1052","article-title":"Absence of glucagon and insulin action reveals a role for the GLP-1 receptor in endogenous glucose production","volume":"64","author":"Jun LS","year":"2015","unstructured":"Jun LS, Millican RL, Hawkins ED, et al.. Absence of glucagon and insulin action reveals a role for the GLP-1 receptor in endogenous glucose production. Diabetes. 2015, 64:819-27. 10.2337\/db14-1052","journal-title":"Diabetes"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.934775","article-title":"Alpha-cell paracrine signaling in the regulation of beta-cell insulin secretion","volume":"13","author":"Holter MM","year":"2022","unstructured":"Holter MM, Saikia M, Cummings BP. Alpha-cell paracrine signaling in the regulation of beta-cell insulin secretion. Front Endocrinol (Lausanne). 2022, 13:934775. 10.3389\/fendo.2022.934775","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1210\/me.2004-0413","article-title":"Akt activation is required at a late stage of insulin-induced GLUT4 translocation to the plasma membrane","volume":"19","author":"van Dam EM","year":"2005","unstructured":"van Dam EM, Govers R, James DE. Akt activation is required at a late stage of insulin-induced GLUT4 translocation to the plasma membrane. Mol Endocrinol. 2005, 19:1067-77. 10.1210\/me.2004-0413","journal-title":"Mol Endocrinol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216179","article-title":"Glucose transporter 4: Insulin response mastermind, glycolysis catalyst and treatment direction for cancer progression","volume":"563","author":"Chang YC","year":"2023","unstructured":"Chang YC, Chan MH, Yang YF, Li CH, Hsiao M. Glucose transporter 4: Insulin response mastermind, glycolysis catalyst and treatment direction for cancer progression. Cancer Lett. 2023, 563:216179. 10.1016\/j.canlet.2023.216179","journal-title":"Cancer Lett"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.5b01238","article-title":"Effects of D-Pinitol on insulin resistance through the PI3K\/Akt signaling pathway in type 2 diabetes mellitus rats","volume":"63","author":"Gao Y","year":"2015","unstructured":"Gao Y, Zhang M, Wu T, Xu M, Cai H, Zhang Z. Effects of D-Pinitol on insulin resistance through the PI3K\/Akt signaling pathway in type 2 diabetes mellitus rats. J Agric Food Chem. 2015, 63:6019-26. 10.1021\/acs.jafc.5b01238","journal-title":"J Agric Food Chem"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12131-x","article-title":"Knockdown of NCAPD3 inhibits the tumorigenesis of non-small cell lung cancer by regulation of the PI3K\/Akt pathway","volume":"24","author":"Yang F","year":"2024","unstructured":"Yang F, Zheng Y, Luo Q, Zhang S, Yang S, Chen X. Knockdown of NCAPD3 inhibits the tumorigenesis of non-small cell lung cancer by regulation of the PI3K\/Akt pathway. BMC Cancer. 2024, 24:408. 10.1186\/s12885-024-12131-x","journal-title":"BMC Cancer"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1186\/ar2941","article-title":"Akt activity protects rheumatoid synovial fibroblasts from Fas-induced apoptosis by inhibition of Bid cleavage","volume":"12","author":"Garc\u00eda S","year":"2010","unstructured":"Garc\u00eda S, Liz M, G\u00f3mez-Reino JJ, Conde C. Akt activity protects rheumatoid synovial fibroblasts from Fas-induced apoptosis by inhibition of Bid cleavage. Arthritis Res Ther. 2010, 12:R33. 10.1186\/ar2941","journal-title":"Arthritis Res Ther"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.13852","article-title":"GLP-1 suppresses glucagon secretion in human pancreatic alpha-cells by inhibition of P\/Q-type Ca(2+) channels","volume":"6","author":"Ramracheya R","year":"2018","unstructured":"Ramracheya R, Chapman C, Chibalina M, et al.. GLP-1 suppresses glucagon secretion in human pancreatic alpha-cells by inhibition of P\/Q-type Ca(2+) channels. Physiol Rep. 2018, 6:e13852. 10.14814\/phy2.13852","journal-title":"Physiol Rep"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2010.04.007","article-title":"GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis","volume":"11","author":"De Marinis YZ","year":"2010","unstructured":"De Marinis YZ, Salehi A, Ward CE, et al.. GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis. Cell Metab. 2010, 11:543-53. 10.1016\/j.cmet.2010.04.007","journal-title":"Cell Metab"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(76)80479-6","article-title":"Isolation and partial characterization of the two major subunits of the BF1 factor (ATPase) from Micrococcus lysodeikticus and evidence for their glycoprotein nature","volume":"65","author":"Andreu JM","year":"1976","unstructured":"Andreu JM, Carreira J, Mu\u00f1oz E. Isolation and partial characterization of the two major subunits of the BF1 factor (ATPase) from Micrococcus lysodeikticus and evidence for their glycoprotein nature. FEBS Lett. 1976, 65:198-203. 10.1016\/0014-5793(76)80479-6","journal-title":"FEBS Lett"},{"key":"ref53","article-title":"Intestinal obstruction: the results of recent experiment applied to clinical practice","volume":"43","author":"Aird I","year":"1936","unstructured":"Aird I. Intestinal obstruction: the results of recent experiment applied to clinical practice. Edinb Med J. 1936, 43:375-94.","journal-title":"Edinb Med J"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1038\/414799a","article-title":"Insulin signalling and the regulation of glucose and lipid metabolism","volume":"414","author":"Saltiel AR","year":"2001","unstructured":"Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001, 414:799-806. 10.1038\/414799a","journal-title":"Nature"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.538","article-title":"Glucagon-like peptide 1(GLP-1) in biology and pathology","volume":"21","author":"Meier JJ","year":"2005","unstructured":"Meier JJ, Nauck MA. Glucagon-like peptide 1(GLP-1) in biology and pathology. Diabetes Metab Res Rev. 2005, 21:91-117. 10.1002\/dmrr.538","journal-title":"Diabetes Metab Res Rev"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1609","article-title":"Relationships between gastric emptying, postprandial glycemia, and incretin hormones","volume":"36","author":"Marathe CS","year":"2013","unstructured":"Marathe CS, Rayner CK, Jones KL, Horowitz M. Relationships between gastric emptying, postprandial glycemia, and incretin hormones. Diabetes Care. 2013, 36:1396-405. 10.2337\/dc12-1609","journal-title":"Diabetes Care"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1369\/0022155415583535","article-title":"Alpha-, delta- and PP-cells: Are they the architectural cornerstones of islet structure and coordination?","volume":"63","author":"Brereton MF","year":"2015","unstructured":"Brereton MF, Vergari E, Zhang Q, Clark A. Alpha-, delta- and PP-cells: Are they the architectural cornerstones of islet structure and coordination?. J Histochem Cytochem. 2015, 63:575-91. 10.1369\/0022155415583535","journal-title":"J Histochem Cytochem"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.1985.248.1.G118","article-title":"Peptide YY inhibits meal-stimulated pancreatic and gastric secretion","volume":"248","author":"Pappas TN","year":"1985","unstructured":"Pappas TN, Debas HT, Goto Y, Taylor IL. Peptide YY inhibits meal-stimulated pancreatic and gastric secretion. Am J Physiol. 1985, 248:G118-23. 10.1152\/ajpgi.1985.248.1.G118","journal-title":"Am J Physiol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1126\/science.179.4068.77","article-title":"Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone","volume":"179","author":"Brazeau P","year":"1973","unstructured":"Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, Guillemin R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science. 1973, 179:77-9. 10.1126\/science.179.4068.77","journal-title":"Science"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1007\/s004240050558","article-title":"Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1","volume":"435","author":"Gromada J","year":"1998","unstructured":"Gromada J, Holst JJ, Rorsman P. Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1. Pflugers Arch. 1998, 435:583-94. 10.1007\/s004240050558","journal-title":"Pflugers Arch"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2024.171179","article-title":"GLP1R and GIPR expression and signaling in pancreatic alpha cells, beta cells and delta cells","volume":"175","author":"Shilleh AH","year":"2024","unstructured":"Shilleh AH, Viloria K, Broichhagen J, Campbell JE, Hodson DJ. GLP1R and GIPR expression and signaling in pancreatic alpha cells, beta cells and delta cells. Peptides. 2024, 175:171179. 10.1016\/j.peptides.2024.171179","journal-title":"Peptides"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.2337\/db14-0849","article-title":"GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans","volume":"63","author":"van Bloemendaal L","year":"2014","unstructured":"van Bloemendaal L, IJzerman RG, Ten Kulve JS, et al.. GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans. Diabetes. 2014, 63:4186-96. 10.2337\/db14-0849","journal-title":"Diabetes"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.10.008","article-title":"Enteroendocrine L cells sense LPS after gut barrier injury to enhance GLP-1 secretion","volume":"21","author":"Lebrun LJ","year":"2017","unstructured":"Lebrun LJ, Lenaerts K, Kiers D, et al.. Enteroendocrine L cells sense LPS after gut barrier injury to enhance GLP-1 secretion. Cell Rep. 2017, 21:1160-8. 10.1016\/j.celrep.2017.10.008","journal-title":"Cell Rep"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-016-3874-y","article-title":"GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial","volume":"59","author":"Farr OM","year":"2016","unstructured":"Farr OM, Sofopoulos M, Tsoukas MA, et al.. GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial. Diabetologia. 2016, 59:954-65. 10.1007\/s00125-016-3874-y","journal-title":"Diabetologia"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2010.01554.x","article-title":"Differential incretin effects of GIP and GLP-1 on gastric emptying, appetite, and insulin-glucose homeostasis","volume":"22","author":"Edholm T","year":"2010","unstructured":"Edholm T, Degerblad M, Gryb\u00e4ck P, et al.. Differential incretin effects of GIP and GLP-1 on gastric emptying, appetite, and insulin-glucose homeostasis. Neurogastroenterol Motil. 2010, 22:1191-200, e315. 10.1111\/j.1365-2982.2010.01554.x","journal-title":"Neurogastroenterol Motil"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2220","article-title":"Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses","volume":"91","author":"Little TJ","year":"2006","unstructured":"Little TJ, Pilichiewicz AN, Russo A, et al.. Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses. J Clin Endocrinol Metab. 2006, 91:1916-23. 10.1210\/jc.2005-2220","journal-title":"J Clin Endocrinol Metab"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.2337\/db10-0474","article-title":"Rapid tachyphylaxis of the glucagon-like peptide 1-induced deceleration of gastric emptying in humans","volume":"60","author":"Nauck MA","year":"2011","unstructured":"Nauck MA, Kemmeries G, Holst JJ, Meier JJ. Rapid tachyphylaxis of the glucagon-like peptide 1-induced deceleration of gastric emptying in humans. Diabetes. 2011, 60:1561-5. 10.2337\/db10-0474","journal-title":"Diabetes"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.1982.242.5.R491","article-title":"Cholecystokinin suppresses food intake by inhibiting gastric emptying","volume":"242","author":"Moran TH","year":"1982","unstructured":"Moran TH, McHugh PR. Cholecystokinin suppresses food intake by inhibiting gastric emptying. Am J Physiol. 1982, 242:R491-7. 10.1152\/ajpregu.1982.242.5.R491","journal-title":"Am J Physiol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3999(88)90008-6","article-title":"Gastric control of food intake","volume":"32","author":"Robinson PH","year":"1988","unstructured":"Robinson PH, McHugh PR, Moran TH, et al.. Gastric control of food intake. J Psychosom Res. 1988, 32:593-606. 10.1016\/0022-3999(88)90008-6","journal-title":"J Psychosom Res"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.073890","article-title":"Glucagon-like peptide-1 limits myocardial stunning following brief coronary occlusion and reperfusion in conscious canines","volume":"312","author":"Nikolaidis LA","year":"2005","unstructured":"Nikolaidis LA, Doverspike A, Hentosz T, Zourelias L, Shen YT, Elahi D, Shannon RP. Glucagon-like peptide-1 limits myocardial stunning following brief coronary occlusion and reperfusion in conscious canines. J Pharmacol Exp Ther. 2005, 312:303-8. 10.1124\/jpet.104.073890","journal-title":"J Pharmacol Exp Ther"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1210\/me.2005-0187","article-title":"Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion","volume":"20","author":"Tsukiyama K","year":"2006","unstructured":"Tsukiyama K, Yamada Y, Yamada C, et al.. Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion. Mol Endocrinol. 2006, 20:1644-51. 10.1210\/me.2005-0187","journal-title":"Mol Endocrinol"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1898","article-title":"Exendin-4, a glucagon-like peptide-1 receptor agonist, prevents osteopenia by promoting bone formation and suppressing bone resorption in aged ovariectomized rats","volume":"28","author":"Ma X","year":"2013","unstructured":"Ma X, Meng J, Jia M, et al.. Exendin-4, a glucagon-like peptide-1 receptor agonist, prevents osteopenia by promoting bone formation and suppressing bone resorption in aged ovariectomized rats. J Bone Miner Res. 2013, 28:1641-52. 10.1002\/jbmr.1898","journal-title":"J Bone Miner Res"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2017.09.018","article-title":"Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)\/protein kinase B (AKT), extracellular signal-related kinase (ERK)1\/2, and cAMP\/protein kinase A (PKA) signaling pathways involving \u03b2-catenin","volume":"360","author":"Wu X","year":"2017","unstructured":"Wu X, Li S, Xue P, Li Y. Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)\/protein kinase B (AKT), extracellular signal-related kinase (ERK)1\/2, and cAMP\/protein kinase A (PKA) signaling pathways involving \u03b2-catenin. Exp Cell Res. 2017, 360:281-91. 10.1016\/j.yexcr.2017.09.018","journal-title":"Exp Cell Res"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1177\/20420188231222367","article-title":"Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications","volume":"15","author":"Alharbi SH","year":"2024","unstructured":"Alharbi SH. Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications. Ther Adv Endocrinol Metab. 2024, 15:20420188231222367. 10.1177\/20420188231222367","journal-title":"Ther Adv Endocrinol Metab"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00248.2012","article-title":"Exendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and activation of SERCA2a","volume":"304","author":"Younce CW","year":"2013","unstructured":"Younce CW, Burmeister MA, Ayala JE. Exendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and activation of SERCA2a. Am J Physiol Cell Physiol. 2013, 304:C508-18. 10.1152\/ajpcell.00248.2012","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2014.04.006","article-title":"Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes","volume":"105","author":"Esser N","year":"2014","unstructured":"Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 2014, 105:141-50. 10.1016\/j.diabres.2014.04.006","journal-title":"Diabetes Res Clin Pract"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2592-3","article-title":"Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes","volume":"55","author":"Lee YS","year":"2012","unstructured":"Lee YS, Park MS, Choung JS, et al.. Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes. Diabetologia. 2012, 55:2456-68. 10.1007\/s00125-012-2592-3","journal-title":"Diabetologia"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1016\/j.genrep.2021.101454","article-title":"Assessment of expression of NF-\u03baB-related genes in periodontitis","volume":"26","author":"Ghafouri-Fard S","year":"2022","unstructured":"Ghafouri-Fard S, Gholami L, Nazer N, et al.. Assessment of expression of NF-\u03baB-related genes in periodontitis. Gene Rep. 2022, 26:101454. 10.1016\/j.genrep.2021.101454","journal-title":"Gene Rep"},{"key":"ref79","article-title":"Immunohistochemical and stereologic analysis of NF-\u03baB activation in chronic periodontitis","volume":"4","author":"Arabaci T","year":"2010","unstructured":"Arabaci T, Cicek Y, Canakci V, Canakci CF, Ozgoz M, Albayrak M, Keles ON. Immunohistochemical and stereologic analysis of NF-\u03baB activation in chronic periodontitis\r\n. Eur J Dent. 2010, 4:454-61.","journal-title":"Eur J Dent"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23569","article-title":"Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway","volume":"51","author":"Gupta NA","year":"2010","unstructured":"Gupta NA, Mells J, Dunham RM, Grakoui A, Handy J, Saxena NK, Anania FA. Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway. Hepatology. 2010, 51:1584-92. 10.1002\/hep.23569","journal-title":"Hepatology"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-012418-012718","article-title":"Diversity, mechanisms, and significance of macrophage plasticity","volume":"15","author":"Locati M","year":"2020","unstructured":"Locati M, Curtale G, Mantovani A. Diversity, mechanisms, and significance of macrophage plasticity. Annu Rev Pathol. 2020, 15:123-47. 10.1146\/annurev-pathmechdis-012418-012718","journal-title":"Annu Rev Pathol"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1177\/00220345211044681","article-title":"Trem1 induces periodontal inflammation via regulating M1 polarization","volume":"101","author":"Wu D","year":"2022","unstructured":"Wu D, Weng Y, Feng Y, Liang B, Wang H, Li L, Wang Z. Trem1 induces periodontal inflammation via regulating M1 polarization. J Dent Res. 2022, 101:437-47. 10.1177\/00220345211044681","journal-title":"J Dent Res"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2022.06.003","article-title":"The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs-Therapeutic potential exploration in lung injury","volume":"12","author":"Pang J","year":"2022","unstructured":"Pang J, Feng JN, Ling W, Jin T. The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs-Therapeutic potential exploration in lung injury. Acta Pharm Sin B. 2022, 12:4040-55. 10.1016\/j.apsb.2022.06.003","journal-title":"Acta Pharm Sin B"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8843310","article-title":"Glucagon-like peptide-1 receptor agonist liraglutide ameliorates the development of periodontitis","volume":"2020","author":"Sawada N","year":"2020","unstructured":"Sawada N, Adachi K, Nakamura N, et al.. Glucagon-like peptide-1 receptor agonist liraglutide ameliorates the development of periodontitis. J Diabetes Res. 2020, 2020:8843310. 10.1155\/2020\/8843310","journal-title":"J Diabetes Res"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M003886200","article-title":"Tumor necrosis factor receptors types 1 and 2 differentially regulate osteoclastogenesis","volume":"275","author":"Abu-Amer Y","year":"2000","unstructured":"Abu-Amer Y, Erdmann J, Alexopoulou L, Kollias G, Ross FP, Teitelbaum SL. Tumor necrosis factor receptors types 1 and 2 differentially regulate osteoclastogenesis. J Biol Chem. 2000, 275:27307-10. 10.1074\/jbc.M003886200","journal-title":"J Biol Chem"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119679","article-title":"Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor","volume":"100","author":"Abu-Amer Y","year":"1997","unstructured":"Abu-Amer Y, Ross FP, Edwards J, Teitelbaum SL. Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. J Clin Invest. 1997, 100:1557-65. 10.1172\/JCI119679","journal-title":"J Clin Invest"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1111\/jre.12607","article-title":"The effect of liraglutide on the proliferation, migration, and osteogenic differentiation of human periodontal ligament cells","volume":"54","author":"Pang Y","year":"2019","unstructured":"Pang Y, Yuan X, Guo J, Wang X, Yang M, Zhu J, Wang J. The effect of liraglutide on the proliferation, migration, and osteogenic differentiation of human periodontal ligament cells. J Periodontal Res. 2019, 54:106-14. 10.1111\/jre.12607","journal-title":"J Periodontal Res"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdent.2020.103310","article-title":"Liraglutide regulates bone destruction and exhibits anti-inflammatory effects in periodontitis in vitro and in vivo","volume":"94","author":"Zhang Y","year":"2020","unstructured":"Zhang Y, Yuan X, Wu Y, et al.. Liraglutide regulates bone destruction and exhibits anti-inflammatory effects in periodontitis in vitro and in vivo. J Dent. 2020, 94:103310. 10.1016\/j.jdent.2020.103310","journal-title":"J Dent"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2015.150278","article-title":"Exenatide and sitagliptin decrease interleukin 1\u03b2, matrix metalloproteinase 9, and nitric oxide synthase 2 gene expression but do not reduce alveolar bone loss in rats with periodontitis","volume":"86","author":"Moraes RM","year":"2015","unstructured":"Moraes RM, Lima GM, Oliveira FE, et al.. Exenatide and sitagliptin decrease interleukin 1\u03b2, matrix metalloproteinase 9, and nitric oxide synthase 2 gene expression but do not reduce alveolar bone loss in rats with periodontitis. J Periodontol. 2015, 86:1287-95. 10.1902\/jop.2015.150278","journal-title":"J Periodontol"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2012.5149","article-title":"Reactive oxygen species in inflammation and tissue injury","volume":"20","author":"Mittal M","year":"2014","unstructured":"Mittal M, Siddiqui MR, Tran K, Reddy SP, Malik AB. Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal. 2014, 20:1126-67. 10.1089\/ars.2012.5149","journal-title":"Antioxid Redox Signal"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2012.09.016","article-title":"Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression","volume":"182","author":"Ojima A","year":"2013","unstructured":"Ojima A, Ishibashi Y, Matsui T, et al.. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression. Am J Pathol. 2013, 182:132-41. 10.1016\/j.ajpath.2012.09.016","journal-title":"Am J Pathol"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12760","article-title":"No disparity of the efficacy and all-cause mortality between Asian and non-Asian type 2 diabetes patients with sodium-glucose cotransporter 2 inhibitors treatment: A meta-analysis","volume":"9","author":"Cai X","year":"2018","unstructured":"Cai X, Gao X, Yang W, et al.. No disparity of the efficacy and all-cause mortality between Asian and non-Asian type 2 diabetes patients with sodium-glucose cotransporter 2 inhibitors treatment: A meta-analysis. J Diabetes Investig. 2018, 9:850-61. 10.1111\/jdi.12760","journal-title":"J Diabetes Investig"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.3390\/dj12090297","article-title":"Asymmetric dimethylarginine as a potential mediator in the association between periodontitis and cardiovascular disease: a systematic review of current evidence","volume":"12","author":"Rapone B","year":"2024","unstructured":"Rapone B, Inchingolo F, Tartaglia GM Jr, De Francesco M, Ferrara E. Asymmetric dimethylarginine as a potential mediator in the association between periodontitis and cardiovascular disease: a systematic review of current evidence. Dent J (Basel). 2024, 12:10.3390\/dj12090297","journal-title":"Dent J (Basel)"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1111\/jre.13087","article-title":"Asymmetric and symmetric dimethylarginine gingival crevicular fluid levels in periodontitis","volume":"58","author":"G\u00fcney Z","year":"2023","unstructured":"G\u00fcney Z, Kurgan S, \u00d6nder C, Mammadov C, Serdar MA, G\u00fcnhan M. Asymmetric and symmetric dimethylarginine gingival crevicular fluid levels in periodontitis. J Periodontal Res. 2023, 58:256-61. 10.1111\/jre.13087","journal-title":"J Periodontal Res"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2001.16.9.1575","article-title":"Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers","volume":"16","author":"Hauge EM","year":"2001","unstructured":"Hauge EM, Qvesel D, Eriksen EF, Mosekilde L, Melsen F. Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers. J Bone Miner Res. 2001, 16:1575-82. 10.1359\/jbmr.2001.16.9.1575","journal-title":"J Bone Miner Res"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.2007-1122","article-title":"In search of the in vivo identity of mesenchymal stem cells","volume":"26","author":"da Silva Meirelles L","year":"2008","unstructured":"da Silva Meirelles L, Caplan AI, Nardi NB. In search of the in vivo identity of mesenchymal stem cells. Stem Cells. 2008, 26:2287-99. 10.1634\/stemcells.2007-1122","journal-title":"Stem Cells"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2008.08.008","article-title":"All MSCs are pericytes?","volume":"3","author":"Caplan AI","year":"2008","unstructured":"Caplan AI. All MSCs are pericytes?. Cell Stem Cell. 2008, 3:229-30. 10.1016\/j.stem.2008.08.008","journal-title":"Cell Stem Cell"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132744","article-title":"Glucagon-like peptide-1 receptor agonist Liraglutide has anabolic bone effects in ovariectomized rats without diabetes","volume":"10","author":"Lu N","year":"2015","unstructured":"Lu N, Sun H, Yu J, et al.. Glucagon-like peptide-1 receptor agonist Liraglutide has anabolic bone effects in ovariectomized rats without diabetes. PLoS One. 2015, 10:e0132744. 10.1371\/journal.pone.0132744","journal-title":"PLoS One"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.6118\/jmm.2015.21.2.93","article-title":"Effect of glucagon-like peptide-1 on the differentiation of adipose-derived stem cells into osteoblasts and adipocytes","volume":"21","author":"Lee HM","year":"2015","unstructured":"Lee HM, Joo BS, Lee CH, Kim HY, Ock JH, Lee YS. Effect of glucagon-like peptide-1 on the differentiation of adipose-derived stem cells into osteoblasts and adipocytes. J Menopausal Med. 2015, 21:93-103. 10.6118\/jmm.2015.21.2.93","journal-title":"J Menopausal Med"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-015-0667-x","article-title":"The bone-preserving effects of exendin-4 in ovariectomized rats","volume":"51","author":"Sun HX","year":"2016","unstructured":"Sun HX, Lu N, Liu DM, et al.. The bone-preserving effects of exendin-4 in ovariectomized rats. Endocrine. 2016, 51:323-32. 10.1007\/s12020-015-0667-x","journal-title":"Endocrine"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80257-3","article-title":"Osf2\/Cbfa1: A transcriptional activator of osteoblast differentiation","volume":"89","author":"Ducy P","year":"1997","unstructured":"Ducy P, Zhang R, Geoffroy V, et al.. Osf2\/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell. 1997, 89:747-54. 10.1016\/S0092-8674(00)80257-3","journal-title":"Cell"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2016.02.002","article-title":"Activation of GLP-1 Receptor Promotes Bone Marrow Stromal Cell Osteogenic Differentiation through \u03b2-Catenin","volume":"6","author":"Meng J","year":"2016","unstructured":"Meng J, Ma X, Wang N, et al.. Activation of GLP-1 Receptor Promotes Bone Marrow Stromal Cell Osteogenic Differentiation through \u03b2-Catenin. Stem Cell Reports. 2016, 6:579-91. 10.1016\/j.stemcr.2016.02.002","journal-title":"Stem Cell Reports"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1016\/j.regpep.2009.06.010","article-title":"Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states","volume":"159","author":"Nuche-Berenguer B","year":"2010","unstructured":"Nuche-Berenguer B, Moreno P, Portal-Nu\u00f1ez S, Dap\u00eda S, Esbrit P, Villanueva-Pe\u00f1acarrillo ML. Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states. Regul Pept. 2010, 159:61-6. 10.1016\/j.regpep.2009.06.010","journal-title":"Regul Pept"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.22-5-849","article-title":"Expression profiling and functional analysis of wnt signaling mechanisms in mesenchymal stem cells","volume":"22","author":"Etheridge SL","year":"2004","unstructured":"Etheridge SL, Spencer GJ, Heath DJ, Genever PG. Expression profiling and functional analysis of wnt signaling mechanisms in mesenchymal stem cells. Stem Cells. 2004, 22:849-60. 10.1634\/stemcells.22-5-849","journal-title":"Stem Cells"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2007.04.174","article-title":"Effects of continuous activation of vitamin D and Wnt response pathways on osteoblastic proliferation and differentiation","volume":"41","author":"Shi YC","year":"2007","unstructured":"Shi YC, Worton L, Esteban L, Baldock P, Fong C, Eisman JA, Gardiner EM. Effects of continuous activation of vitamin D and Wnt response pathways on osteoblastic proliferation and differentiation. Bone. 2007, 41:87-96. 10.1016\/j.bone.2007.04.174","journal-title":"Bone"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M706105200","article-title":"Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation","volume":"283","author":"Liu Z","year":"2008","unstructured":"Liu Z, Habener JF. Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation. J Biol Chem. 2008, 283:8723-35. 10.1074\/jbc.M706105200","journal-title":"J Biol Chem"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/cdg599","article-title":"Osteocyte control of bone formation via sclerostin, a novel BMP antagonist","volume":"22","author":"Winkler DG","year":"2003","unstructured":"Winkler DG, Sutherland MK, Geoghegan JC, et al.. Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J. 2003, 22:6267-76. 10.1093\/emboj\/cdg599","journal-title":"EMBO J"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M807994200","article-title":"Characterization of the structural features and interactions of sclerostin: molecular insight into a key regulator of Wnt-mediated bone formation","volume":"284","author":"Veverka V","year":"2009","unstructured":"Veverka V, Henry AJ, Slocombe PM, et al.. Characterization of the structural features and interactions of sclerostin: molecular insight into a key regulator of Wnt-mediated bone formation. J Biol Chem. 2009, 284:10890-900. 10.1074\/jbc.M807994200","journal-title":"J Biol Chem"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2013.01.001","article-title":"Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST\/sclerostin in osteocytes","volume":"92","author":"Kim JY","year":"2013","unstructured":"Kim JY, Lee SK, Jo KJ, et al.. Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST\/sclerostin in osteocytes. Life Sci. 2013, 92:533-40. 10.1016\/j.lfs.2013.01.001","journal-title":"Life Sci"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1007\/s11302-016-9526-3","article-title":"c-Fos induction by gut hormones and extracellular ATP in osteoblastic-like cell lines","volume":"12","author":"Pacheco-Pantoja EL","year":"2016","unstructured":"Pacheco-Pantoja EL, Dillon JP, Wilson PJ, Fraser WD, Gallagher JA. c-Fos induction by gut hormones and extracellular ATP in osteoblastic-like cell lines. Purinergic Signal. 2016, 12:647-51. 10.1007\/s11302-016-9526-3","journal-title":"Purinergic Signal"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.18.7260","article-title":"Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells","volume":"87","author":"Udagawa N","year":"1990","unstructured":"Udagawa N, Takahashi N, Akatsu T, et al.. Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci U S A. 1990, 87:7260-4. 10.1073\/pnas.87.18.7260","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00098","article-title":"The impact of glucagon-like peptide-1 on bone metabolism and its possible mechanisms","volume":"8","author":"Zhao C","year":"2017","unstructured":"Zhao C, Liang J, Yang Y, Yu M, Qu X. The impact of glucagon-like peptide-1 on bone metabolism and its possible mechanisms. Front Endocrinol (Lausanne). 2017, 8:98. 10.3389\/fendo.2017.00098","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(96)00895-2","article-title":"Expression of glucagon-like peptide-1 receptor in a murine C cell line: regulation of calcitonin gene by GLP-1","volume":"393","author":"Lamari Y","year":"1996","unstructured":"Lamari Y, Boissard C, Moukhtar MS, et al.. Expression of glucagon-like peptide-1 receptor in a murine C cell line: regulation of calcitonin gene by GLP-1. FEBS Lett. 1996, 393:248-52. 10.1016\/0014-5793(96)00895-2","journal-title":"FEBS Lett"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1210\/en.2009-1272","article-title":"Glucagon-like peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation","volume":"151","author":"Bjerre Knudsen L","year":"2010","unstructured":"Bjerre Knudsen L, Madsen LW, Andersen S, et al.. Glucagon-like peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation. Endocrinology. 2010, 151:1473-86. 10.1210\/en.2009-1272","journal-title":"Endocrinology"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1210\/en.2007-1292","article-title":"The murine glucagon-like peptide-1 receptor is essential for control of bone resorption","volume":"149","author":"Yamada C","year":"2008","unstructured":"Yamada C, Yamada Y, Tsukiyama K, et al.. The murine glucagon-like peptide-1 receptor is essential for control of bone resorption. Endocrinology. 2008, 149:574-9. 10.1210\/en.2007-1292","journal-title":"Endocrinology"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5783639","article-title":"The glucagon-like peptide-1 receptor agonist exendin-4 inhibits lipopolysaccharide-induced osteoclast formation and bone resorption via inhibition of TNF-\u03b1 expression in macrophages","volume":"2018","author":"Shen WR","year":"2018","unstructured":"Shen WR, Kimura K, Ishida M, et al.. The glucagon-like peptide-1 receptor agonist exendin-4 inhibits lipopolysaccharide-induced osteoclast formation and bone resorption via inhibition of TNF-\u03b1 expression in macrophages. J Immunol Res. 2018, 2018:5783639. 10.1155\/2018\/5783639","journal-title":"J Immunol Res"},{"key":"ref117","article-title":"Effects of Exenatide-4 on proliferation, migration and osteogenic differentiation of human periodontal ligament stem cells","volume":"29","author":"Liang QY","year":"2020","unstructured":"Liang QY, DU LQ, Zhang R, Ding T, Ge SH. Effects of Exenatide-4 on proliferation, migration and osteogenic differentiation of human periodontal ligament stem cells. Shanghai Kou Qiang Yi Xue. 2020, 29:225-30.","journal-title":"Shanghai Kou Qiang Yi Xue"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2018.03.014","article-title":"Exendin-4 relieves the inhibitory effects of high glucose on the proliferation and osteoblastic differentiation of periodontal ligament stem cells","volume":"91","author":"Guo Z","year":"2018","unstructured":"Guo Z, Chen R, Zhang F, Ding M, Wang P. Exendin-4 relieves the inhibitory effects of high glucose on the proliferation and osteoblastic differentiation of periodontal ligament stem cells. Arch Oral Biol. 2018, 91:9-16. 10.1016\/j.archoralbio.2018.03.014","journal-title":"Arch Oral Biol"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1515\/med-2023-0692","article-title":"Exendin-4 regulates the MAPK and WNT signaling pathways to alleviate the osteogenic inhibition of periodontal ligament stem cells in a high glucose environment","volume":"18","author":"Wang M","year":"2023","unstructured":"Wang M, Liu M, Zheng J, Xiong L, Wang P. Exendin-4 regulates the MAPK and WNT signaling pathways to alleviate the osteogenic inhibition of periodontal ligament stem cells in a high glucose environment. Open Med (Wars). 2023, 18:20230692. 10.1515\/med-2023-0692","journal-title":"Open Med (Wars)"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2018.12.001","article-title":"Periodontitis and mechanisms of cardiometabolic risk: novel insights and future perspectives","volume":"1865","author":"Mesa F","year":"2019","unstructured":"Mesa F, Magan-Fernandez A, Castellino G, Chianetta R, Nibali L, Rizzo M. Periodontitis and mechanisms of cardiometabolic risk: novel insights and future perspectives. Biochim Biophys Acta Mol Basis Dis. 2019, 1865:476-84. 10.1016\/j.bbadis.2018.12.001","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8260111","article-title":"Therapeutic potential of liraglutide for diabetes-periodontitis comorbidity: Killing two birds with one stone","volume":"2022","author":"Yang M","year":"2022","unstructured":"Yang M, Pang Y, Pei M, Li Y, Yuan X, Tang R, Wang J. Therapeutic potential of liraglutide for diabetes-periodontitis comorbidity: Killing two birds with one stone. J Diabetes Res. 2022, 2022:8260111. 10.1155\/2022\/8260111","journal-title":"J Diabetes Res"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.00324-14","article-title":"Tannin degradation by a novel tannase enzyme present in some Lactobacillus plantarum strains","volume":"80","author":"Jim\u00e9nez N","year":"2014","unstructured":"Jim\u00e9nez N, Esteban-Torres M, Manche\u00f1o JM, de Las Rivas B, Mu\u00f1oz R. Tannin degradation by a novel tannase enzyme present in some Lactobacillus plantarum strains. Appl Environ Microbiol. 2014, 80:2991-7. 10.1128\/AEM.00324-14","journal-title":"Appl Environ Microbiol"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.14219\/jada.archive.2011.0342","article-title":"Periodontal ligament and intraosseous anesthetic injection techniques: alternatives to mandibular nerve blocks","volume":"142","author":"Moore PA","year":"2011","unstructured":"Moore PA, Cuddy MA, Cooke MR, Sokolowski CJ. Periodontal ligament and intraosseous anesthetic injection techniques: alternatives to mandibular nerve blocks. J Am Dent Assoc. 2011, 142:13S-8S. 10.14219\/jada.archive.2011.0342","journal-title":"J Am Dent Assoc"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.24953\/turkjped.2019.04.009","article-title":"Cranial MR characteristics of cerebral palsy cases and correlation with clinical results","volume":"61","author":"Ali A","year":"2019","unstructured":"Ali A, Yal\u00e7\u0131n R, \u00dcnl\u00fcer-G\u00fcm\u00fc\u015fta\u015f A. Cranial MR characteristics of cerebral palsy cases and correlation with clinical results. Turk J Pediatr. 2019, 61:525-37. 10.24953\/turkjped.2019.04.009","journal-title":"Turk J Pediatr"},{"key":"ref125","unstructured":"Treatment of arthrosis by incretin hormones or their analogues. (2012). Accessed. September 14, 2025: https:\/\/patentscope.wipo.int\/search\/en\/WO2014023923."},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S83322","article-title":"GLP-1 reduces metalloproteinase-9 induced by both hyperglycemia and hypoglycemia in type 1 diabetes. The possible role of oxidative stress","volume":"11","author":"Ceriello A","year":"2015","unstructured":"Ceriello A, La Sala L, De Nigris V, Pujadas G, Rondinelli M, Genovese S. GLP-1 reduces metalloproteinase-9 induced by both hyperglycemia and hypoglycemia in type 1 diabetes. The possible role of oxidative stress. Ther Clin Risk Manag. 2015, 11:901-3. 10.2147\/TCRM.S83322","journal-title":"Ther Clin Risk Manag"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0765.2004.00696.x","article-title":"Effects of sub-antimicrobial dose doxycycline therapy on crevicular fluid MMP-8, and gingival tissue MMP-9, TIMP-1 and IL-6 levels in chronic periodontitis","volume":"39","author":"Choi DH","year":"2004","unstructured":"Choi DH, Moon IS, Choi BK, Paik JW, Kim YS, Choi SH, Kim CK. Effects of sub-antimicrobial dose doxycycline therapy on crevicular fluid MMP-8, and gingival tissue MMP-9, TIMP-1 and IL-6 levels in chronic periodontitis. J Periodontal Res. 2004, 39:20-6. 10.1111\/j.1600-0765.2004.00696.x","journal-title":"J Periodontal Res"},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.1177\/154405910608500110","article-title":"Gingival tissue and crevicular fluid co-operation in adult periodontitis","volume":"85","author":"Beklen A","year":"2006","unstructured":"Beklen A, T\u00fcter G, Sorsa T, Hanemaaijer R, Virtanen I, Tervahartiala T, Konttinen YT. Gingival tissue and crevicular fluid co-operation in adult periodontitis. J Dent Res. 2006, 85:59-63. 10.1177\/154405910608500110","journal-title":"J Dent Res"},{"key":"ref129","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0765.2006.00888.x","article-title":"Levels of matrix metalloproteinases-8 and -9 with simultaneous presence of periodontal pathogens in gingival crevicular fluid as well as matrix metalloproteinase-9 and cholesterol in blood","volume":"41","author":"S\u00f6der B","year":"2006","unstructured":"S\u00f6der B, Airila M\u00e5nsson S, S\u00f6der PO, Kari K, Meurman J. Levels of matrix metalloproteinases-8 and -9 with simultaneous presence of periodontal pathogens in gingival crevicular fluid as well as matrix metalloproteinase-9 and cholesterol in blood. J Periodontal Res. 2006, 41:411-7. 10.1111\/j.1600-0765.2006.00888.x","journal-title":"J Periodontal Res"},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2006.050293","article-title":"Expression of matrix metalloproteinases (MMP-8 and -9) in chronic periodontitis patients with and without diabetes mellitus","volume":"77","author":"Kumar MS","year":"2006","unstructured":"Kumar MS, Vamsi G, Sripriya R, Sehgal PK. Expression of matrix metalloproteinases (MMP-8 and -9) in chronic periodontitis patients with and without diabetes mellitus. J Periodontol. 2006, 77:1803-8. 10.1902\/jop.2006.050293","journal-title":"J Periodontol"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.2009.01512.x","article-title":"Gingival crevicular fluid levels of MMP-8, MMP-9, TIMP-2, and MPO decrease after periodontal therapy","volume":"37","author":"Marcaccini AM","year":"2010","unstructured":"Marcaccini AM, Meschiari CA, Zuardi LR, et al.. Gingival crevicular fluid levels of MMP-8, MMP-9, TIMP-2, and MPO decrease after periodontal therapy. J Clin Periodontol. 2010, 37:180-90. 10.1111\/j.1600-051X.2009.01512.x","journal-title":"J Clin Periodontol"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0765.2011.01416.x","article-title":"Full-mouth profile of active MMP-8 in periodontitis patients","volume":"47","author":"Kraft-Neum\u00e4rker M","year":"2012","unstructured":"Kraft-Neum\u00e4rker M, Lorenz K, Koch R, Hoffmann T, M\u00e4ntyl\u00e4 P, Sorsa T, Netuschil L. Full-mouth profile of active MMP-8 in periodontitis patients. J Periodontal Res. 2012, 47:121-8. 10.1111\/j.1600-0765.2011.01416.x","journal-title":"J Periodontal Res"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.4103\/2229-3019.148262","article-title":"Role of matrix metalloproteinases in periodontitis and its management","volume":"1","author":"Charles K","year":"2014","unstructured":"Charles K, Honibald EN, Raghavendra RN, et al.. Role of matrix metalloproteinases in periodontitis and its management. J Indian Acad Dent Spec Res. 2014, 1:65-9. 10.4103\/2229-3019.148262","journal-title":"J Indian Acad Dent Spec Res"},{"key":"ref134","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.2009.01488.x","article-title":"Proteolytic roles of matrix metalloproteinase (MMP)-13 during progression of chronic periodontitis: initial evidence for MMP-13\/MMP-9 activation cascade","volume":"36","author":"Hern\u00e1ndez R\u00edos M","year":"2009","unstructured":"Hern\u00e1ndez R\u00edos M, Sorsa T, Obreg\u00f3n F, et al.. Proteolytic roles of matrix metalloproteinase (MMP)-13 during progression of chronic periodontitis: initial evidence for MMP-13\/MMP-9 activation cascade. J Clin Periodontol. 2009, 36:1011-7. 10.1111\/j.1600-051X.2009.01488.x","journal-title":"J Clin Periodontol"},{"key":"ref135","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-051x.2001.028004353.x","article-title":"Longitudinal evaluation of GCF MMP-3 and TIMP-1 levels as prognostic factors for progression of periodontitis","volume":"28","author":"Alpagot T","year":"2001","unstructured":"Alpagot T, Bell C, Lundergan W, Chambers DW, Rudin R. Longitudinal evaluation of GCF MMP-3 and TIMP-1 levels as prognostic factors for progression of periodontitis. J Clin Periodontol. 2001, 28:353-9. 10.1034\/j.1600-051x.2001.028004353.x","journal-title":"J Clin Periodontol"},{"key":"ref136","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2003-4-6-216","article-title":"Matrix metalloproteinases: old dogs with new tricks","volume":"4","author":"Somerville RP","year":"2003","unstructured":"Somerville RP, Oblander SA, Apte SS. Matrix metalloproteinases: old dogs with new tricks. Genome Biol. 2003, 4:216. 10.1186\/gb-2003-4-6-216","journal-title":"Genome Biol"},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.1002\/jemt.10374","article-title":"Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities","volume":"61","author":"Delaiss\u00e9 JM","year":"2003","unstructured":"Delaiss\u00e9 JM, Andersen TL, Engsig MT, Henriksen K, Troen T, Blavier L. Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities. Microsc Res Tech. 2003, 61:504-13. 10.1002\/jemt.10374","journal-title":"Microsc Res Tech"},{"key":"ref138","doi-asserted-by":"publisher","DOI":"10.1042\/CS20060274","article-title":"Regulation and enzymatic basis of bone resorption by human osteoclasts","volume":"112","author":"Fuller K","year":"2007","unstructured":"Fuller K, Kirstein B, Chambers TJ. Regulation and enzymatic basis of bone resorption by human osteoclasts. Clin Sci (Lond). 2007, 112:567-75. 10.1042\/CS20060274","journal-title":"Clin Sci (Lond)"},{"key":"ref139","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2004.06.015","article-title":"Effects of the phytoestrogen coumestrol on RANK-ligand-induced differentiation of osteoclasts","volume":"203","author":"Kanno S","year":"2004","unstructured":"Kanno S, Hirano S, Kayama F. Effects of the phytoestrogen coumestrol on RANK-ligand-induced differentiation of osteoclasts. Toxicology. 2004, 203:211-20. 10.1016\/j.tox.2004.06.015","journal-title":"Toxicology"},{"key":"ref140","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2011.106","article-title":"Diabetes mellitus and periodontitis: a tale of two common interrelated diseases","volume":"7","author":"Lalla E","year":"2011","unstructured":"Lalla E, Papapanou PN. Diabetes mellitus and periodontitis: a tale of two common interrelated diseases. Nat Rev Endocrinol. 2011, 7:738-48. 10.1038\/nrendo.2011.106","journal-title":"Nat Rev Endocrinol"},{"key":"ref141","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa757","article-title":"Effect of periodontitis treatment on incretin axis in obese and nonobese individuals: a cohort study","volume":"106","author":"Suvan J","year":"2021","unstructured":"Suvan J, Masi S, Harrington Z, Santini E, Raggi F, D'Aiuto F, Solini A. Effect of periodontitis treatment on incretin axis in obese and nonobese individuals: a cohort study. J Clin Endocrinol Metab. 2021, 106:e74-82. 10.1210\/clinem\/dgaa757","journal-title":"J Clin Endocrinol Metab"},{"key":"ref142","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-021-01583-3","article-title":"Clinical and radiographic variables related to implants with simultaneous grafts among type 2 diabetic patients treated with different hypoglycemic medications: a retrospective study","volume":"21","author":"Shi S","year":"2021","unstructured":"Shi S, Ding F, Liu X, et al.. Clinical and radiographic variables related to implants with simultaneous grafts among type 2 diabetic patients treated with different hypoglycemic medications: a retrospective study. BMC Oral Health. 2021, 21:214. 10.1186\/s12903-021-01583-3","journal-title":"BMC Oral Health"},{"key":"ref143","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjoms.2015.05.023","article-title":"Potential mechanism for osseointegration of dental implants in Zucker diabetic fatty rats","volume":"53","author":"Liu Z","year":"2015","unstructured":"Liu Z, Zhou W, Tangl S, Liu S, Xu X, Rausch-Fan X. Potential mechanism for osseointegration of dental implants in Zucker diabetic fatty rats. Br J Oral Maxillofac Surg. 2015, 53:748-53. 10.1016\/j.bjoms.2015.05.023","journal-title":"Br J Oral Maxillofac Surg"},{"key":"ref144","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2022.2036873","article-title":"Construction and performance of exendin-4-loaded chitosan-PLGA microspheres for enhancing implant osseointegration in type 2 diabetic rats","volume":"29","author":"Shi S","year":"2022","unstructured":"Shi S, Song S, Liu X, et al.. Construction and performance of exendin-4-loaded chitosan-PLGA microspheres for enhancing implant osseointegration in type 2 diabetic rats. Drug Deliv. 2022, 29:548-60. 10.1080\/10717544.2022.2036873","journal-title":"Drug Deliv"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/419810-glucagon-like-peptide-1-glp-1-receptor-agonists-in-diabetes-and-obesity-implications-for-periodontology-and-family-dentistry","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:31:01Z","timestamp":1761895861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/419810-glucagon-like-peptide-1-glp-1-receptor-agonists-in-diabetes-and-obesity-implications-for-periodontology-and-family-dentistry"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":144,"URL":"https:\/\/doi.org\/10.7759\/cureus.95792","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,31]]}}}